0001528172-19-000001.txt : 20191122 0001528172-19-000001.hdr.sgml : 20191122 20191122140242 ACCESSION NUMBER: 0001528172-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 EFFECTIVENESS DATE: 20191122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDONOVO THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001528172 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452552528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-354045 FILM NUMBER: 191240494 BUSINESS ADDRESS: STREET 1: 6320 CANOGA AVENUE STREET 2: 15TH FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: (800) 489-4774 MAIL ADDRESS: STREET 1: 6320 CANOGA AVENUE STREET 2: 15TH FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 FORMER COMPANY: FORMER CONFORMED NAME: Hanover Portfolio Acquisitions, Inc. DATE OF NAME CHANGE: 20110920 FORMER COMPANY: FORMER CONFORMED NAME: Hanover Portfoliio Acquisitions, Inc. DATE OF NAME CHANGE: 20110817 D 1 primary_doc.xml X0708 D LIVE 0001528172 ENDONOVO THERAPEUTICS, INC. 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA CALIFORNIA 91367 (800) 489-4774 DELAWARE Hanover Portfolio Acquisitions, Inc. Hanover Portfoliio Acquisitions, Inc. Corporation true Collier Collier 6320 Conoga Avenue 15th Floor Woodland Hills CA CALIFORNIA 91367 Executive Officer Director Michael Mann 6320 Conoga Avenue 15th Floor Woodland Hills CA CALIFORNIA 91367 Executive Officer Biotechnology $1 - $1,000,000 06c false 2019-10-31 false true false 25000 2000000 225000 1775000 false 4 0 0 0 All proceeds are working capital false ENDONOVO THERAPEUTICS, INC. Frank J Hariton Frank J Hariton Assistant Secretary 2019-11-22